Olivier Clerc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Olivier Clerc has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Sharmila Dorbala
Brigham and Women’s Hospital
7 shared publications - Rodney H. Falk
Harvard Medical School and Brigham and Women’s Hospital, Boston, MA (R.H.F.).
6 shared publications - Sarah A. M. Cuddy
Brigham and Women’s Hospital
6 shared publications Marie Foley
5 shared publications- Shilpa Vijayakumar
Brigham and Women’s Hospital
5 shared publications Marcelo F
4 shared publications
Latest Publications
- Open Access
- 17 October 2026
- Published by Springer Nature
- p. 205-236
Future Directions
To learn about emerging applications of molecular imaging with positron emission tomography (PET) in cardiovascular disease. To understand the potential applications of PET in the diagnosis and management of patients with cardiac amyloidosis. To learn about the potential utility of PET in the diagnosis of myocarditis. To learn about the potential utility of novel radiotracers for PET imaging to assess thrombosis, fibrosis, calcification, and inflammation in cardiovascular disease.
- 17 October 2026
- Published by Springer Nature
- p. 205-236
Open AccessFuture Directions
To learn about emerging applications of molecular imaging with positron emission tomography (PET) in cardiovascular disease. To understand the potential applications of PET in the diagnosis and management of patients with cardiac amyloidosis. To learn about the potential utility of PET in the diagnosis of myocarditis. To learn about the potential utility of novel radiotracers for PET imaging to assess thrombosis, fibrosis, calcification, and inflammation in cardiovascular disease.
- 17 December 2024
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 42, 102087
The heart has a memory: Let's not forget to interrogate it with 18F-FDG PET
- 17 December 2024
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 42, 102087
The heart has a memory: Let's not forget to interrogate it with 18F-FDG PET
- 11 May 2024
- Published by Morressier GmbH
Functional Capacity in Light Chain Amyloid Cardiomyopathy: Prognostic Value and Changes With Therapy PA135 (#543)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
- 11 May 2024
- Published by Morressier GmbH
Functional Capacity in Light Chain Amyloid Cardiomyopathy: Prognostic Value and Changes With Therapy PA135 (#543)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
- 11 May 2024
- Published by Morressier GmbH
Temporal Changes in Cardiac Amyloid Burden Assessed Using 124I-Evuzamitide PET/CT PB142 (#537)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
- 11 May 2024
- Published by Morressier GmbH
Temporal Changes in Cardiac Amyloid Burden Assessed Using 124I-Evuzamitide PET/CT PB142 (#537)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
- 11 May 2024
- Published by Morressier GmbH
Cardiac Involvement in Rare Forms of Amyloidosis Assessed Using 124I-Evuzamitide PET/CT PB141 (#536)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
- 11 May 2024
- Published by Morressier GmbH
Cardiac Involvement in Rare Forms of Amyloidosis Assessed Using 124I-Evuzamitide PET/CT PB141 (#536)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
- 11 May 2024
- Published by Morressier GmbH
Quantification of Left Atrial Amyloid Burden in Light Chain Amyloidosis: A 18F-Florbetapir PET/CT Study PB146 (#571)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
- 11 May 2024
- Published by Morressier GmbH
Quantification of Left Atrial Amyloid Burden in Light Chain Amyloidosis: A 18F-Florbetapir PET/CT Study PB146 (#571)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
- 10 May 2024
- Published by Morressier GmbH
Longitudinal Changes in Quantitative 99mTc-PYP SPECT/CT Myocardial Metrics with Transthyretin Stabilization Therapy in Transthyretin Cardiac Amyloidosis PB132 (#488)
Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was do | POSTER
- 10 May 2024
- Published by Morressier GmbH
Longitudinal Changes in Quantitative 99mTc-PYP SPECT/CT Myocardial Metrics with Transthyretin Stabilization Therapy in Transthyretin Cardiac Amyloidosis PB132 (#488)
Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was do | POSTER
- 9 May 2024
- Published by Morressier GmbH
Automatic quantification of AL and ATTR amyloidosis disease burden using 124I-evuzamitide, a novel radiotracer PB120 (#416)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
- 9 May 2024
- Published by Morressier GmbH
Automatic quantification of AL and ATTR amyloidosis disease burden using 124I-evuzamitide, a novel radiotracer PB120 (#416)
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER